The Patient's Journey - the Time to Final Diagnosis in Patients With SiNET
NCT03840720 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2020-04-28
Summary
"The patient's journey" is an interview based study assessing the patients' experience from the first symptoms to a final diagnosis focusing on patients with small intestinal neuroendocrine tumors.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
Vastra Gotaland Region
lead OTHER_GOV
Principal Investigators
-
Andreas Hallqvist, MD, PhD · Dept of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-01
- Primary Completion
- 2019-07-31
- Completion
- 2019-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer
NCT04592913 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
NCT00227773 ·Status: WITHDRAWN ·Phase: PHASE2
-
Intraperitoneal Chemotherapy Guided by the Detection of DNA in Peritoneal Lavage Fluid in Patients With Gastric Cancer
NCT05497739 ·Status: UNKNOWN ·Phase: PHASE2
-
A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer
NCT06555471 ·Status: RECRUITING ·Phase: PHASE2
-
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
NCT00287768 ·Status: COMPLETED ·Phase: PHASE3
-
Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer
NCT00669370 ·Status: UNKNOWN ·Phase: PHASE2
-
Short Course Radiotherapy With Sequential Disitamab Vedotin Combined With S-1 and Sintilimab as Whole Course Neoadjuvant Therapy for HER2 Expressed Locally Progressive Gastric Cancer
NCT06487429 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Neoadjuvant Chemoradiation Plus Serplulimab in Patients With Locally Advanced Adenocarcinoma of Gastroesophageal Junction
NCT05918419 ·Status: UNKNOWN ·Phase: PHASE2
-
Early IntraVenous Administration of Nutritional Support
NCT03949907 ·Status: TERMINATED ·Phase: NA
-
Chemotherapy for Patients With Cancer of the Stomach
NCT01928524 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
NCT05773274 ·Status: RECRUITING ·Phase: PHASE2
-
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors
NCT02016534 ·Status: TERMINATED ·Phase: PHASE2
-
Drug Sensitivity Screening for Gastrointestinal Cancer
NCT04298489 ·Status: UNKNOWN ·Phase: NA
-
Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer
NCT01525771 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
NCT03061058 ·Status: UNKNOWN ·Phase: PHASE3
-
Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
NCT00683787 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
NCT05184803 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer
NCT01291407 ·Status: COMPLETED ·Phase: PHASE1
-
Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer
NCT01515748 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
NCT00515190 ·Status: UNKNOWN ·Phase: PHASE2
-
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT05702229 ·Status: RECRUITING ·Phase: PHASE2
-
S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer
NCT00343668 ·Status: UNKNOWN ·Phase: PHASE2
-
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
NCT00737438 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Vinflunine in Patients With Gastric Cancer
NCT00359476 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
NCT00515216 ·Status: COMPLETED ·Phase: PHASE2